147,533
Participants
Start Date
November 20, 2019
Primary Completion Date
July 31, 2023
Study Completion Date
January 31, 2024
HCV Screening
The investigators will perform a prospective pragmatic randomized effectiveness trial that will allow the investigators to directly compare 2 HCV screening methods while minimizing threats to internal validity. Patients will be screened for HCV infection using 1 of 2 interventions using a balanced patient-level random allocation scheme built into existing EHRs for each ED.
Johns Hopkins University, Baltimore
University of Mississippi Medical Center, Jackson
Denver Health Medical Center, Denver
Collaborators (1)
Johns Hopkins University
OTHER
University of Mississippi Medical Center
OTHER
Boston University
OTHER
Boston Medical Center
OTHER
University of Cincinnati
OTHER
Alameda County Medical Center
OTHER
Denver Health and Hospital Authority
OTHER